United States · FDA National Drug Code directory
Vyzulta
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24208-504_12648511-1ae2-aaf8-e063-6394a90a2297
- Product NDC
- 24208-504
- Form
- SOLUTION/ DROPS
- Composition / generic term
- latanoprostene bunod
- Labeler
- Bausch & Lomb Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20171102
- Source listing expiry
- 20261231
Source-listed ingredients
- LATANOPROSTENE BUNOD — .24 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (24208-504-01) / 2.5 mL in 1 BOTTLE · 24208-504-01
- 1 BOTTLE in 1 CARTON (24208-504-02) / 2.5 mL in 1 BOTTLE · 24208-504-02
- 1 BOTTLE in 1 CARTON (24208-504-05) / 5 mL in 1 BOTTLE · 24208-504-05
- 1 BOTTLE in 1 CARTON (24208-504-06) / 5 mL in 1 BOTTLE · 24208-504-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →